Peripheral Vascular Stents Market Size, Share, Trends & Analysis | Global | 2020-2026 | MedCore | Segmented by: Type (Bare-Metal, Covered, Drug-Eluting)
- Year: 2020
- Scope: 10 Years
- Region: Global
- Type: MedCore
The global peripheral vascular stents market size is expected to reach over $3,828 million by 2026, with the drug-eluting stent market segment showing the highest growth rate.
The majority of the global peripheral vascular stents share was controlled by W.L. Gore, Boston Scientific and Medtronic. Overall, this global market research includes an analysis of peripheral vascular stents manufacturing companies spawning across more than 70 countries in the world.
Stents are commonly used as complementary devices during conventional percutaneous transluminal angioplasty (PTA) balloon catheterization in peripheral vascular procedures. The placement of a stent mitigates some complications such as negative remodelling and elastic recoil effects. However, post-surgery complications such as restenosis occur in up to a half of patients who have undergone PTA.
Peripheral Vascular Stents Market Data Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Peripheral Vascular Stent Procedure Volumes
- Market Drivers & Limiters
- Market Forecasts Until 2026, and Historical Data to 2016
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
Peripheral Vascular Stent Procedure Volumes
Through the study on the global peripheral vascular market, iData Research has performed an analysis on arterial stenting, peripheral angioplasty, atherectomy, CTO crossing, AAA stent graft placements, TAA stent-graft placements, surgical graft procedures, vascular closure procedures and intravascular ultrasound procedure volumes in order to increase the accuracy of our market sizing, and provide you with the volume of procedures over a 10-year range and across 70 countries.
Peripheral Vascular Stent Market Insights
The high price of devices within the covered stent market segment, and the large uptake in use, will result in it becoming the largest segment of the North American peripheral vascular stent market by 2020. The drug-eluting stent (DES) market suffered a significant shock in 2019 following the Katsanos metanalysis published in 2018 in the Journal of the American Heart Association. However, the market is expected to recover quickly, due to additional clinical evidence that has been published since August 2019 and manufacturer development of DESs
Peripheral Vascular Stent Market Share Insights
The global peripheral vascular stent market was controlled by three key competitors – W.L. Gore, Boston Scientific and Medtronic.
Medtronic’s leading position in the total bare-metal stent market is derived from its strong presence in the high-value iliac and femoral-popliteal segments of the market.
W. L. Gore holds a large portion of the high-value covered stent segment with its VIABAHN® portfolio. VIABAHN® devices sell at a modest premium to other covered stents on the market, such as iCast® and Fluency®.
Boston Scientific is a significant player in the iliac and renal stent segments, with its Express® LD iliac stent and Express® SD stents.
Research Regional Coverage
Throughout this research series, iData Research has covered over 70 countries across the globe in great detail. Each global region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:
- North America (the United States and Canada)
- Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
- Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
- Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
- Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
- Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
- Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
Market Segmentation Summary
- Bare-Metal Stent Market
- Covered Stent Market
- Drug-Eluting Stent Market
About Our In-Depth MedCore Research
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis of a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment and provides further detailed segmentation to get a much more granular set of market data.
This MedCore is also found in the full report suite titled Global Market Report Suite for Peripheral Vascular Devices – MedSuite
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.